🔎 Trials Near Me

Utama › Leukemia Mieloid Akut › California › Baldwin Park

Kajian klinikal Leukemia Mieloid Akut di Baldwin Park, CA

40 kajian untuk Leukemia Mieloid Akut sedang mencari peserta di lokasi dalam dan sekitar Baldwin Park (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Mengambil pesertaFasa 2/3
  • City of Hope National Medical Center /ID# 279568, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07581002

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Mengambil pesertaFasa 1
  • City of Hope, Duarte · 4 mi jauh
Umur 12 hingga 78 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT03802695

A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Mengambil pesertaFasa 1
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06763341

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

Mengambil pesertaFasa 3
  • Clinical Trial Site, Duarte · 4 mi jauh
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07211958

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Mengambil pesertaFasa 3
  • City of Hope, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06852222

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Mengambil pesertaFasa 3
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauh
6 Months – 21 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04293562

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Mengambil pesertaFasa 2
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT04996875

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

Mengambil pesertaFasa 1
  • City of Hope National Medical Center, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06846606

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
  • City of Hope, Duarte · 4 mi jauh
Umur 12 hingga 120 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT05436418

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

Mengambil pesertaFasa 1/2
  • City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06969430

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Mengambil pesertaFasa 1/2
  • City of Hope National Medical Center, Duarte · 4 mi jauh
Umur 12 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT04588922

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Mengambil pesertaFasa 1
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07025564

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

Mengambil pesertaFasa 1
  • City of Hope, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT06533761

8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia

Mengambil pesertaFasa 1
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT05263284

Individualized AML Treatment

Mengambil pesertaKajian pemerhatian
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT07613385

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Jul 2026 · NCT07020533

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Mengambil pesertaFasa 3
  • City of Hope Comprehensive Cancer Center - Duarte, Duarte · 4 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 17 Jul 2026 · NCT05429632

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

Mengambil pesertaFasa 1
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 16 Jul 2026 · NCT06498973

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Mengambil pesertaKajian pemerhatian
  • City of Hope, Duarte · 4 mi jauh
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

Mengambil pesertaFasa 1
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 1 Jul 2026 · NCT06996119

A Study of Revumenib and Mezigdomide in People With Leukemia

Mengambil pesertaFasa 1/2
  • City of Hope Cancer Center (Data collection only), Duarte · 4 mi jauh
Umur 12 ke atas · Semua jantina · Dikemas kini 22 Jun 2026 · NCT07356154

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Mengambil pesertaFasa 1
  • City of Hope, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Jun 2026 · NCT03113643

Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 60 ke atas · Semua jantina · Dikemas kini 29 Apr 2026 · NCT06195891

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

Mengambil pesertaFasa 1
  • City of Hope, Duarte · 4 mi jauh
Sehingga umur 21 · Semua jantina · Dikemas kini 22 Apr 2026 · NCT05101551

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

Mengambil pesertaFasa 1
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Apr 2026 · NCT06146257

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Mengambil pesertaFasa 1
  • City of Hope, Duarte · 4 mi jauh
Umur 12 ke atas · Semua jantina · Dikemas kini 16 Mac 2026 · NCT06994676

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 10 Mac 2026 · NCT06059391

CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia

Mengambil pesertaFasa 1
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mac 2026 · NCT05672147

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

Mengambil pesertaFasa 1
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mac 2026 · NCT06543381

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

Mengambil pesertaFasa 1
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 2 ke atas · Semua jantina · Dikemas kini 5 Mac 2026 · NCT06575296

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

Mengambil pesertaFasa 1
  • City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mi jauh
Umur 65 ke atas · Semua jantina · Dikemas kini 16 Dis 2025 · NCT06552416

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

Mengambil pesertaFasa 1
  • City of Hope - Duarte, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Okt 2025 · NCT06549790

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Mengambil pesertaFasa 1
  • City of Hope Medical Center, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2025 · NCT06501196

Study of REM-422 in Patients With AML or Higher Risk MDS

Mengambil pesertaFasa 1
  • City of Hope, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Apr 2025 · NCT06297941

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Mengambil pesertaFasa 1
  • City of Hope National Medical Center, Duarte · 4 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mac 2024 · NCT04243785

Kajian Leukemia Mieloid Akut di bandar lain

Kajian lain di Baldwin Park

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.